CRSP

Q: What is the price of CRISPR Therapeutics (CRSP) today?

The price of CRISPR Therapeutics (CRSP) today is US$ 71,82, with a variation of 49.47% compared to the last year. The price of CRISPR Therapeutics (CRSP) started the year trading around US$ 39,36 and today it is at US$ 71,82. Follow the real-time price chart, the historical price of CRISPR Therapeutics (CRSP), and stock data from Ibovespa and international markets.

Q: When does CRISPR Therapeutics (CRSP) pay dividends?

CRISPR Therapeutics (CRSP) não distribuiu dividendos no último ano.

Q: CRISPR Therapeutics (CRSP) is it worth it?

Currently, CRISPR Therapeutics (CRSP) is priced at US$ 71,82, with a P/E of -10,77%, representing a deviation of -6,27% from its historical average P/E. In the last year, the stock showed a variation of 49.47% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 49,47%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of CRISPR Therapeutics (CRSP)?

Investing in stocks of CRISPR Therapeutics (CRSP) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of CRISPR Therapeutics (CRSP) yield today?

The yield of CRISPR Therapeutics (CRSP) was 24,17% in the last month, 49,47% in the last year and -33,33% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of CRISPR Therapeutics (CRSP) today, the total investment would be US$ 7.182,00, based on the current price of US$ 71,82.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 10.734,94In 5 years: US$ 4.788,24In 10 years: 7.182,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CRISPR Therapeutics AG

Price

US$ 71,82

variation (12m)

49,47%

p/l

-10,77

p/vp

3,72

DIVIDEND YIELD

0,00%

price CRSP

BVMF

CRSP

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of CRSP

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

24,17%

3 months

30,37%

1 year

49,47%

2 years

64,50%

5 years

-33,33%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

24,17%

3 months

29,89%

1 year

42,91%

2 years

50,14%

5 years

-50,73%

10 years

0,00%

Indicators CRSP

check out the fundamentals of CRISPR Therapeutics shares

P/E

-10,77

Sector: -3,49 Industry: -3,49

P/SALES RATIO (PSR)

181,63

Sector: -4,23 Industry: -4,23

P/BV

3,72

Sector: 1,90 Industry: 1,90

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-29,09%

Sector: -63,54% Industry: -63,54%

ROE

-34,50%

Sector: -70,19% Industry: -70,19%

ROIC

-290,60%

Sector: -2.095,92% Industry: -2.095,92%

NET MARGIN

-100,00%

Sector: -41,67% Industry: -41,67%

GROSS MARGIN

-100,00%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

-100,00%

Sector: -41,04% Industry: -41,04%

P/EBITDA

-9,74

Sector: -3,69 Industry: -3,69

P/EBIT

-9,46

Sector: -3,68 Industry: -3,68

P/ASSET

3,13

Sector: 1,42 Industry: 1,42

BVPS

19,67

Sector: 1,85 Industry: 1,85

EPS

-6,79

Sector: -2,19 Industry: -2,19

EQUITY / ASSETS

0,84

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

118,18%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

9,70%

Sector: - Industry: -

CRSP indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,99	5,85	32,50%	2,66%	US$ 458,87 B	27,75%
PFE	15,32	1,58	10,33%	6,90%	US$ 140,87 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	15,47	9,74	62,99%	2,96%	US$ 253,17 B	34,74%
MRK	12,21	4,40	36,03%	3,77%	US$ 215,83 B	28,16%
AZN	28,13	5,85	20,79%	1,85%	US$ 262,04 B	16,23%
BMY	17,14	5,05	29,44%	5,67%	US$ 88,25 B	10,71%
GILD	20,79	7,45	35,82%	2,68%	US$ 145,89 B	24,71%
ZTS	23,71	12,62	53,20%	1,37%	US$ 62,79 B	28,00%
HALO	13,25	23,31	175,93%	0,00%	US$ 7,76 B	48,21%
REGN	13,15	1,98	15,06%	0,47%	US$ 59,29 B	31,83%
AMGN	29,90	21,01	70,29%	3,24%	US$ 156,09 B	14,67%
VRTX	28,91	6,10	21,11%	0,00%	US$ 104,80 B	31,22%
MCK	25,75	-110,60	-429,55%	0,39%	US$ 95,44 B	0,97%
CAH	26,89	-14,13	-52,54%	1,30%	US$ 37,22 B	0,60%
ADMA	16,91	8,80	52,03%	0,00%	US$ 3,50 B	43,51%
BIIB	12,13	1,22	10,08%	0,00%	US$ 21,55 B	17,46%
HRMY	8,66	1,96	22,58%	0,00%	US$ 1,51 B	22,19%

comparison of CRSP with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History CRSP

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY CRISPR Therapeutics

CRISPR Therapeutics AG

Average user rating I10

4.0 (9 people)

Estados Unidos

12 years

Foundation: 2013

2016

Year of debut on the stock exchange - 9 years

93

Employees

The Company CRISPR Therapeutics AG (Estados Unidos), is listed on Nasdaq with a market value of $ 6,36 Billions, having a net worth of $ 1,71 Billion.

With a total of 93 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 35,00 Milhões, which generated a loss in the amount of $ -590,41 Milhões.

As for its main indicators, the Company has a P/E ratio of -10,77, a P/BV ratio of 3,72 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker CRSP.

Market value

US$ 6,36 Billions

Net worth

US$ 1,71 Billion

US$ 1.711.120.000,00

Assets

US$ 2,03 Billions

US$ 2.029.710.000,00

Total Number of Shares

87,00 Milhões

87.000.000

Average Daily Trading Volume

US$ 2,59 Milhões

US$ 2.592.777,32

Sector

Health Care

Industry

Biotechnology

CRSP

CRSP revenue and profits

CRSP results

DRAG THE FRAME TO SEE MORE DATA

CRSP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CRSP

CRISPR Therapeutics AG

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of CRSP

check out the fundamentals of CRISPR Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY CRISPR Therapeutics

CRISPR Therapeutics AG

Estados Unidos

12 years

2016

93

PROFIT X PRICE CRSP

CRSP results

CRSP cash flow

evolution of assets - CRSP

CRSP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions